Skip to Content

Pacer BioThreat Strategy ETF VIRS ETF Analysis

| Medalist Rating as of | See Pacer Investment Hub

Morningstar’s Analysis VIRS

Will VIRS outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Pacer BioThreat Strategy ETF retains its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research


The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor